ELS 1
Latest Information Update: 25 Jul 1994
At a glance
- Originator Pierre Fabre Italia
- Class Antineoplastics; Small molecules
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer